跳至主要内容
临床试验/NCT00187564
NCT00187564已完成不适用

Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2004年8月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
1. protein carbonyl (measurement of oxidized protein)

研究概览

简要总结

The long-term effects of high blood sugar include blindness, kidney failure, and nerve damage that can ultimately cause loss of limbs. Research has shown that high blood sugar increases the amount of reactive oxygen species (ROS) produced in diabetics, and that the increase in ROS causes damage to eyes, kidneys, and nerves by a process called "oxidative stress." We postulate that alpha-lipoic acid, a potent anti-oxidant, can stop ROS from forming, thereby preventing long-term complications in diabetes. In this pilot study, we will be giving 30 teenagers with type 1 diabetes (T1D) controlled-release alpha-lipoic acid for 3 months, and comparing the amount of oxidative stress before and after treatment. Ten teenagers with T1D will receive placebo instead of alpha-lipoic acid and undergo the same research protocol to aid in validation of outcome measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
8 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects must be pubertal (defined as Tanner stage II or greater), or post-pubertal, with an upper age limit of 21 years.
  • •Subjects must have diabetes by 1997 ADA criteria:
  • •fasting plasma glucose >= 126 mg/dL, or
  • •2 hour postprandial glucose >= 200 mg/dL
  • •Subjects must have history of least one auto-antibody associated with T1D, either glutamic acid decarboxylase (GADA) or islet cell autoantigen 512 (ICA512), or history of diabetic ketoacidosis.

排除标准

  • •1. Subjects must not have history of eye, kidney or nerve damage
  • •Subjects must not be deemed unable or unlikely to comply with the protocol. Children who are unable to swallow pills, or are unwilling to take pills twice daily will be excluded from the study.

结局指标

主要结局

1. protein carbonyl (measurement of oxidized protein)

2. Thiobarbituric Acid Reactive Substances (TBARS) (measurement of oxidized lipid)

3. 8-Oxo-dG/8-Oxo-dA (measurement of oxidized DNA)

4. Trolox equivalent antioxidant capacity (TEAC) (measurement of total antioxidant status)

次要结局

  • 1. Hb A1c
  • 2. Urine albumin/creatinine ratio

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验